Dear Sir, In a very interesting article published in the European Journal of Nuclear Medicine and Molecular Imaging [1], Flotats et al. provide reasonable and interesting findings about the use of Rb PET in the evaluation of patients with and without coronary artery disease (CAD). It is widely accepted that, due to the small risk of complications related to conventional coronary angiography, which has up to now been the gold standard for detecting CAD, noninvasive cardiac imaging is now central to the diagnosis and management of patients with known or suspected CAD. Nuclear cardiology has played an important role in recent years: single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) has been widely validated for the diagnosis and prognosis of cardiac disease, and the technique is heavily embedded in national and international guidelines [2]. In recent years, after a long period dominated by SPECT imaging, the availability of promising perfusion PET tracers such as Rb (1995) and, more recently, N-ammonia has led to various studies comparing PET and SPECT techniques. Although data obtained more than 15 years ago support the superiority of PET over SPECT for diagnosing CAD, it is unclear whether PET would still be found to be superior because of major advances in SPECT instrumentation [3] and imaging protocols [4]. The excellent work by Flotats et al., although comparing PET with standard protocol SPECT acquisition, seems to indicate that PET perfusion imaging may be a better weapon to help nuclear cardiology survive the test of time. It is undoubtedly clear that more recently cardiac magnetic resonance (CMR) may be able to play an important role in CAD detection and evaluation. During a reasonably short acquisition time (on average 45–60 min) CMR may offer a comprehensive cardiac assessment, including qualitative and quantitative functional analysis, detection of valve anomalies, accurate demonstration of infarct size and identification of inducible ischaemia [5]. Information from scanning the heart during pharmacologically induced stress is also provided. With regard to the other noninvasive techniques, a range of agents (i.e. dobutamine, adenosine, dipyridamole) are available, but adenosine is the most widely used because major cardiac events are rare and because the short half-life of the drug allows easier and safer management of patients both under normal conditions and in the event of adverse events. After the administration of adenosine, inducible ischaemia may be indirectly heralded by the onset of regional wall motion abnormalities demonstrated by the acquisition of cine MR images; however, the sensitivity of this technique is quite poor. More commonly, the effects of adenosine are directly assessed through the acquisition of a stack of images with high temporal resolution (typically one image every heartbeat) during the first pass of a bolus of gadolinium-based contrast agent. Although a compromise must be reached between temporal resolution, spatial resolution and image coverage, on modern scanners stress perfusion may be assessed in at least three short-axis sections. When the patient’s heart rate allows it, one or two long-axis sections F. Caobelli (*) : C. Pizzocaro :U. P. Guerra Department of Nuclear Medicine, Fondazione Poliambulanza, Via Bissolati 57, 25100 Brescia, Italy e-mail: fedefournier@libero.it